- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Starting Jan. 1, 2026, CMS is establishing a repository where covered entities participating in the 340B drug discount program can voluntarily submit Medicare Part D claims data related to 340B drugs -- a policy brand drug industry representatives say could be populated with the help of the upcoming pilot program permitting drug companies to issue rebate payments for 340B drugs instead traditional upfront discounts.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us